Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study
NCT: NCT07487701 · COMPLETED
Brief Summary
Preventive pharmacologic therapies for migraine aim to reduce attack frequency and duration and improve quality of life; however, their use, overall benefit and adherence are often limited. Remote electrical neuromodulation (REN) is a non-invasive FDA-cleared wearable device for acute and/or preventive migraine treatment. This study will evaluate the real-world efficacy and patient-reported outcomes of preventive REN use over 3 months in migraine patients.
Frequently Asked Questions
What is Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study?
Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study is a clinical trial registered under NCT07487701. Current status: COMPLETED.
What is the status of NCT07487701?
The current status of NCT07487701 (Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study) is: COMPLETED.
When did Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study start?
Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study started on 2026-02-20.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.